Mycobacterium tuberculosis inhibits optimal T helper type 1 (Th1) responses during infection. However, the precise mechanisms by which virulent M. tuberculosis limits Th1 responses remain unclear. Here, we infected dendritic cells (DCs) with the virulent M. tuberculosis strain H37Rv or the attenuated strain H37Ra to investigate the phenotypic and functional alterations in DCs and resultant T-cell responses. H37Rv-infected DCs suppressed Th1 responses more strongly than H37Ra-infected DCs. Interestingly, H37Rv, but not H37Ra, impaired DC surface molecule expression (CD80, CD86 and MHC class II) due to prominent interleukin-10 (IL-10) production while augmenting the expression of tolerogenic molecules including PD-L1, CD103, Tim-3 and indoleamine 2,3-dioxygenase on DCs in a multiplicity-of-infection (MOI) -dependent manner. These results indicate that virulent M. tuberculosis drives immature DCs toward a tolerogenic phenotype. Notably, the tolerogenic phenotype of H37Rv-infected DCs was blocked in DCs generated from IL-10 À/À mice or DCs treated with an IL-10-neutralizing monoclonal antibody, leading to restoration of Th1 polarization. These findings suggest that IL-10 induces a tolerogenic DC phenotype. Interestingly, p38 mitogenactivated protein kinase (MAPK) activation predominantly mediates IL-10 production; hence, H37Rv tends to induce a tolerogenic DC phenotype through expression of tolerogenic molecules in the p38 MAPK-IL-10 axis. Therefore, suppressing the tolerogenic cascade in DCs is a novel strategy for stimulating optimal protective T-cell responses against M. tuberculosis infection.
Summary
Mycobacterium tuberculosis inhibits optimal T helper type 1 (Th1) responses during infection. However, the precise mechanisms by which virulent M. tuberculosis limits Th1 responses remain unclear. Here, we infected dendritic cells (DCs) with the virulent M. tuberculosis strain H37Rv or the attenuated strain H37Ra to investigate the phenotypic and functional alterations in DCs and resultant T-cell responses. H37Rv-infected DCs suppressed Th1 responses more strongly than H37Ra-infected DCs. Interestingly, H37Rv, but not H37Ra, impaired DC surface molecule expression (CD80, CD86 and MHC class II) due to prominent interleukin-10 (IL-10) production while augmenting the expression of tolerogenic molecules including PD-L1, CD103, Tim-3 and indoleamine 2,3-dioxygenase on DCs in a multiplicity-of-infection (MOI) -dependent manner. These results indicate that virulent M. tuberculosis drives immature DCs toward a tolerogenic phenotype. Notably, the tolerogenic phenotype of H37Rv-infected DCs was blocked in DCs generated from IL-10
Introduction
Mycobacterium tuberculosis is a successful human bacterial pathogen that causes tuberculosis (TB), one of the major causes of human death by infection. 1 Despite the great time and effort spent researching M. tuberculosis, elucidation of its pathogenesis remains ongoing. A robust T helper type 1 (Th1) response has widely been considered essential for providing immunity against TB. 2 However, M. tuberculosis possesses diverse immune evasion mechanisms that can overcome host defences during infection. Once targeted cells of the host such as Abbreviations: BMDCs, bone marrow-derived DCs; DCs, dendritic cells; ELISA, enzyme-linked immunosorbent assay; ERK, extracellular signal-regulated kinase; HRP, horseradish peroxidase; IDO, indoleamine 2,3-dioxygenase; IFN-c, interferon-c; IL, interleukin; JNK, Jun-N-terminal kinase; mAbs, monoclonal antibodies; MAPK, mitogen-activated protein kinase; MOI, multiplicity of infection; PE, phycoerythrin; PerCP, Peridinin chlorophyll protein; TB, tuberculosis; TGF-b, transforming growth factor-b; Th1, T helper type 1; TNF-a, tumour necrosis factor-a; WT, wild-type
I M M U N O L O G Y O R I G I N A L A R T I C L E
macrophages and dendritic cells (DCs) are infected by M. tuberculosis, these cells attempt to kill the M. tuberculosis via cellular processes such as autophagy and phagosome-lysosome fusion. However, if the host cells fail to control M. tuberculosis growth, the bacteria survive and manipulate host cells for immune evasion. 3, 4 Although the cellular mechanisms shared between immune defence and evasion are relatively well-studied, the phenotypic and functional alterations of M. tuberculosis-infected immune cells are not yet clearly understood.
The genetic diversity of M. tuberculosis results in variation in virulence that induces marked differences in pathogenesis, 5 including bacterial counts, and in immune responses, such as lung inflammation, chemokine and cytokine profiles, 6 and cell death processes. 7 In addition, the outcome of protective T-cell immunity clearly depends on the M. tuberculosis strain. Hence, differences in virulence among M. tuberculosis strains may initially affect the function and phenotype of antigen-presenting cells, such as DCs. For example, the virulent strain H37Rv, but not the attenuated strain H37Ra, induces necrosis by disrupting the mitochondrial inner membrane, 7 and H37Rv up-regulates Th2-type cytokines such as interleukin-5 (IL-5), IL-10 and IL-13 compared with H37Ra in macrophages in vitro. 6 As another example, the virulent strain S7 from South India suppresses the Th1 response more than the less virulent strain S10. 8 Hence, investigating different cell death processes, cytokine secretion profiles, and effector expression levels in DCs in the presence of different bacterial strains of varying virulence is essential to determine the optimal Th1-type T-cell response during the early phase of infection and to understand how virulent M. tuberculosis subverts host protective immunity.
Dendritic cells are the most important antigen-presenting cells for defending M. tuberculosis infection because they prime and educate T cells in draining lymph nodes. Consequently, these T cells migrate to infected tissues to combat M. tuberculosis. Hence, the generation of protective Th1-type T cells against M. tuberculosis infection depends on the speed or mechanism by which different DCs translate and deliver information about the infection to T cells. In other words, the initial encounter between DCs and M. tuberculosis is the first critical step that determines the type and velocity of the T-cell response. Hence, understanding the nature of DC maturation and phenotypic changes in response to M. tuberculosis strains of varying virulence is of great interest for the development of an effective TB vaccine and new immunological interventions to control M. tuberculosis infection.
It is well documented that DCs differentiate into mature phenotype in response to various inflammatory stimuli, such as microbial products or cytokines, and then prime na€ ıve T cells to proliferate and engage in an effective T-cell immune response. In general, mature DCs are characterized according to phenotypic and functional changes, such as enhanced expression of MHC class I and II molecules, co-stimulatory molecules (CD80, CD86, and CD40) and a variety of innate cytokines. With respect to M. tuberculosis infection, DCs perform important functions in containing and killing M. tuberculosis by inducing T-cell responses. 3, 9 After DCs take up M. tuberculosis, they migrate to secondary lymphoid organs to prime T cells. Activated T cells proliferate and migrate to the site of infection. Once a sufficient number of effector T cells accumulates at the infection site, M. tuberculosis growth becomes hindered. However, T-cell responses to M. tuberculosis infection are relatively delayed and impaired compared with T-cell responses to infection with other intracellular pathogens. 10 The mechanism underlying the delay in T-cell responses to M. tuberculosis infection is currently uncertain, but several studies reported that IL-10 is one factor that is involved in this delay. 11, 12 The levels of immunoregulatory cytokines, such as IL-5, IL-10 and IL-13, are increased in monocytes and monocyte-derived macrophages in the presence of a virulent strain of M. tuberculosis compared with those in an attenuated strain. 6, 13 Many studies have reported that innate and adaptive cells are associated with pathogenesis during M. tuberculosis infection.
14 However, the interaction between the DC phenotype according to M. tuberculosis virulence and the T-cell response has not been thoroughly studied.
One mechanism by which virulent M. tuberculosis might subvert T-cell responses could be alteration of DC function and phenotype. Hence, in this study, we hypothesized that a highly virulent M. tuberculosis strain would drive immature DCs towards a tolerogenic phenotype, thereby preventing an optimal Th1 response. To address this hypothesis, we infected DCs with the two most thoroughly studied laboratory-adapted reference strains M. tuberculosis H37Rv and H37Ra, which are virulent and attenuated strains, respectively, to gain insight into DC responses and consequent changes in T-cell polarization. In addition, we dissected the precise mechanism by which virulent M. tuberculosis regulates the phenotype and function of DCs. These findings will help us to understand how TB manipulates the host immune system toward pathogen-favouring conditions by interacting with DCs.
Materials and methods

Experimental animals and ethics statement
Specific pathogen-free female 6-to 8-week-old wild-type (WT) C57BL/6 (H-2Kb and I-Ab), IL-10 À/À transgenic C57BL/6, and OT-II ovalbumin peptide 323-339 (OVA 323-339 ) specific T-cell receptor transgenic C57BL/6 mice were purchased from the Jackson Laboratory (Bar 
Mycobacterium tuberculosis strains and culture conditions
The M. tuberculosis H37Rv (ATCC 27294) and H37Ra (ATCC 25177) strains were obtained from the American Type Culture Collection (ATCC, Manassas, VA). The cultures and single-cell suspensions of each strain were prepared as previously described. 15 The seed lots of each strain were kept in small aliquots at À80°until use. After confirmation of the predominant presence of single cells in the final preparation based on acid-fast staining, the number of colony-forming units (CFUs) per 1 ml of each seed lot on a 7H10 agar plate was measured using a viable cell counting assay, and the cells were used for the subsequent experiments.
Generation and culture of bone marrow-derived DCs (BMDCs)
Generation and culture of DCs from murine bone marrow cells were performed in the presence of GM-CSF as previously described. 16 Briefly, whole bone marrow cells isolated from C57BL/6 mice were lysed with red blood cell lysing buffer and washed with RPMI-1640 medium. Then, the cells were plated in six-well culture plates (10 6 cells/ml) and incubated at 37°in a 5% CO 2 atmosphere in RPMI-1640 medium supplemented with 100 U/ml penicillin/ streptomycin (Lonza, Basel, Switzerland), 10% fetal bovine serum (Lonza), 50 lM mercaptoethanol (Lonza), 0Á1 mM non-essential amino acids (Lonza), and 20 ng/ml GM-CSF. On day 8, the purity of CD11c-positive non-adherent cells was confirmed to be > 90%, and this cell population was used for subsequent experiments.
Comparison of cytotoxicity between M. tuberculosis strains and determination of MOIs not causing cytotoxicity to DCs At 8 days in culture, DCs (2 9 10 6 cells) were infected with H37Ra or H37Rv at a MOI of 0Á5, 1 or 5. After 4 hr, amikacin (Sigma-Aldrich) was applied at 20 µg/ml to kill any extracellular bacteria. After an additional 18 hr, the DCs were harvested, washed with PBS, and stained using an Annexin V-PI Apoptosis Detection Kit (BD Biosciences) according to the manufacturer's protocol. Furthermore, the levels of lactate dehydrogenase (LDH) in the supernatants of M. tuberculosis-infected DCs were assessed to evaluate DC cytotoxicity. To measure the viability of the DCs at prolonged time-points (48, 72 and 96 hr post-M. tuberculosis infection), the M. tuberculosis-infected DCs were stained using LIVE/ DEAD â Fixable Dead Cell Stain Kits according to the manufacturer's protocol and analysed using flow cytometry.
Comparison of M. tuberculosis uptake by DCs
To determine whether DCs uptake a similar number of the different M. tuberculosis strains, both M. tuberculosis strains were labelled with the fluorescent Violet Proliferation Dye 450 (VPD450; BD Biosciences) according to the manufacturer's instructions. Briefly, the M. tuberculosis strains (2 9 10 8 CFU/ml) were washed with PBS, diluted in 1 ml of PBS supplemented with 10 lM of VPD450 and incubated in a 37°water bath for 15-20 min. Finally, the VPD450-labelled M. tuberculosis strains were washed twice in PBS, and the DCs were infected at an MOI of 1 bacterium per cell and analysed at various time-points. After each time-point, the DCs were harvested, the noninternalized bacteria were washed off with PBS, and 0Á2% trypan blue was added to the cells. M. tuberculosis inside DCs were measured using flow cytometry.
Evaluation of cell surface molecule expression on DCs using flow cytometry
On day 8 in culture, the BMDCs were harvested and washed once. Then, 2 9 10 6 DCs/ml were infected with M. tuberculosis for 4 hr. Afterwards, Amikacin was applied at 20 µg/ml. After an additional 18 hr, the harvested cells were blocked with 10% (volume/volume) normal goat serum for 15 min at 4°, followed by staining with PE-conjugated antibodies against I-Ab (MHC-II), CD80, or PD-L1, allophycocyanin-conjugated antibodies against CD86, CD103 or Tim-3, and a PE-Cy7-conjugated antibody against CD11c for 30 min at 4°. Finally, the stained cells were analysed using a BD FACSverse flow cytometer (Becton Dickinson, San Jose, CA) and FLOWJO software (Tree Star, Inc., Ashland, OR).
ELISA
Supernatants were collected 24 hr after infection and were stored at À70°until assessment of cytokine production. The levels of TNF-a, TGF-b, IL-5, IL-10, IL-12p70, IL-17A and IFN-c were measured using sandwich ELISA kits (eBioscience) and commercially available pairs of antibodies and standards according to the manufacturer's protocol.
Immunoblotting analyses and treatment of DCs with pharmacological inhibitors of GSK-3b and mitogenactivated protein kinase pathway members
After infection with M. tuberculosis, DCs were lysed in 200 ll of lysis buffer containing 50 mM Tris-HCl (pH 7Á5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 50 mM NaF, 30 mM Na 4 PO 7 , 1 mM PMSF, 2 lg/ml aprotinin, and 1 mM pervanadate. Whole-cell lysate samples were resolved on SDS-polyacrylamide gels and then transferred to polyvinylidene fluoride membrane for 2 hr at 80 V. The membranes were blocked in 5% skim milk and incubated with an antibody overnight, followed by incubation with a corresponding HRP-conjugated secondary antibody for 1 hr at room temperature. For detection of target protein epitopes, polyclonal antibodies against p-ERK 1/2, p-JNK 1/2, p-p38, p-Akt (Ser473), and p-GSK-3b (Ser9) (dilutions of 1 : 2000, 1 : 2000, 1 : 2000, 1 : 2000, and 1 : 500, respectively) were used. Specific protein bands recognized by the antibodies were visualized using the ECL Advance Western Blotting Detection kit (GE Healthcare, Little Chalfont, UK). Two hours before M. tuberculosis infection, inhibitors of ERK (U0126), JNK (JNK 2 inhibitor), p38 (SB203580), or GSK-3b (Wortmannin) were applied. After 4 hr of M. tuberculosis infection, DCs were treated with 20 µg/ml amikacin, and after an additional 18 hr, the supernatants were harvested and analysed using ELISA kits.
T-cell proliferation assay
OVA 323-339 -specific CD4 + T cells were obtained from the splenocytes of OT-II mice a MACS column (Miltenyi Biotec, Bergisch Gladbach, Germany). These T cells were stained with 1Á25 lM carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen). One hour before co-culture with T cells, DCs (2 9 10 6 cells/well) were treated with OVA 323-339 . Then, the DCs were co-cultured with CFSE-stained CD4 + T cells (2Á5 9 10 5 cells/well) at a DC : T-cell ratio of 1 : 5. At 3 days in co-culture, the T cells were stained with PerCP-Cy5.5-conjugated anti-CD4, PE-Cy7-conjugated anti-T-bet, PE-conjugated anti-GATA-3 and anti-RORct mAbs and analysed through flow cytometry. Supernatants were also harvested, and the IFN-c, IL-5 and IL-17A levels were measured via ELISA.
T-cell suppression by M. tuberculosis-infected tolerogenic DCs
To investigate whether M. tuberculosis H37Rv-infected tolerogenic DCs are actively involved in T-cell suppression, we conducted a T-cell suppression assay using previously described protocols with slight modifications. [17] [18] [19] Briefly, BMDCs were harvested and infected with M. tuberculosis as described above. After 24 hr, the BMDCs (3 9 10 4 cells/well) were washed and co-cultured for 72 hr with CD4 + T cells (1Á5 9 10 5 cells/well) isolated from the spleen using a MACS system. CD4 + T cells were labelled with 1Á25 lM CFSE and stimulated with immobilized anti-CD3/28. T-cell proliferation was analysed via flow cytometry.
Statistical analyses
Statistical analyses were conducted using GRAPHPAD PRISM V5Á0 (GraphPad Software, San Diego, CA). Differences between two groups were analysed using an unpaired Student's t-test. One-way analyses of variance followed by Tukey's multiple comparison tests were used to analyse data with more than two groups. All values are expressed as the means (AE SD). Statistical significance was determined as *P < 0Á05, **P < 0Á01 or ***P < 0Á001.
Results
Virulent M. tuberculosis strain-infected DCs impede T-cell proliferation
As previously reported, an impaired and delayed T-cell response is a unique hallmark of M. tuberculosis infection, 20 and DCs infected with M. tuberculosis impede T-cell proliferation. 21 To determine the effect of M. tuberculosis infection in DCs on the T-cell response, we first optimized the MOI of M. tuberculosis that would not cause DC death and could therefore be used in subsequent experiments for flow cytometry analysis (see + T cells were labelled with CFSE and co-cultured with M. tuberculosis-infected DCs at a 5 : 1 ratio for 3 days (Fig. 1) . Interestingly, virulent M. tuberculosis strain H37Rv-infected DCs showed a weaker ability to induce naive CD4 + T-cell proliferation than attenuated H37Ra-infected DCs or non-infected OVA 323-339 -pulsed DCs (Fig. 1a,b) . Next, to verify the types of T-cell responses induced by M. tuberculosisinfected DCs, the expression of transcription factors and cytokines related to Th1 (T-bet and IFN-c) and Th2 responses (GATA-3 and IL-5) and Th17 (RORct and IL-17A) in co-cultured CD4 + T cells was analysed via flow cytometry (Fig. 1c,d ) and ELISA (Fig. 1e) . Compared with H37Rv-infected DCs, H37Ra-infected DCs induced stronger T-bet and IFN-c expression in co-cultured T cells. RORct expression in T cells as well as IL-17A secretion were higher in T cells subjected to M. tuberculosis-infected DCs, but there was no difference between the two strains. T cells co-cultured with non-infected OVA 323-339 -pulsed DCs showed the highest expression levels of GATA-3, but the overall expression levels of GATA-3 and IL-5 were not intense in every sample (Fig. 1d,e To investigate the reason that virulent M. tuberculosis H37Rv-infected DCs ineffectively induced T-cell responses, we measured the expression levels of surface molecules related to T-cell activation on DCs (Fig. 2) . The gating strategy for each surface molecule and enzyme is shown in Fig. 2(a) . H37Ra-infected DCs displayed increasing expression of CD80 and CD86 as the MOI increased, but H37Rv-infected DCs presented reduced expression of CD80 and CD86 as the MOI increased. H37Rv but not H37Ra repressed the expression of MHC-II as the MOI increased. Moreover, both M. tuberculosis strains up-regulated CCR7 compared with its expression in non-infected DCs, and H37Rv-infected DCs exhibited up-regulation of CCR7 in an MOI-dependent manner (Fig. 2b) . Next, the expression of inhibitory molecules such as PD-L1, Tim-3, CD103 and IDO was analysed via flow cytometry (Fig. 2c) . H37Rv-infected DCs displayed higher expression of PD-L1, Tim-3, CD103 and IDO than H37Ra-infected DCs, and infection at higher MOIs further induced these molecules. These results suggest that the virulent M. tuberculosis strain H37Rv induces a more tolerogenic DC phenotype than the attenuated M. tuberculosis strain H37Ra.
The virulent M. tuberculosis strain induces marked IL-10 production in DCs
Cytokine signalling is a crucial regulator of DC-T-cell interactions. To verify the cytokine profiles of DCs infected with different M. tuberculosis strains, the TNF-a, IL-10 and IL-12p70 levels in cell culture supernatants were measured (Fig. 3) . After 24 hr of M. tuberculosis infection at an MOI of 0Á5 or 1, H37Rv-infected DCs secreted two-fold greater levels of TNF-a than H37Ra-infected DCs (Fig. 3a) . Remarkably, H37Rv-infected DCs induced three-fold greater secretion of IL-10 than H37Ra-infected DCs; however, IL-12p70 was not detected in cells infected with either M. tuberculosis strain. To evaluate the kinetics of each cytokine, DCs were infected with either M. tuberculosis strains at an MOI of 1, and the TNF-a, IL-10 and IL-12p70 levels were then measured via ELISA at 2, 4, 8, 12 and 24 hr after infection (Fig. 3b) . TNF-a was secreted at high levels at the early time-points, and the secreted level of TNF-a peaked at 8 hr after infection in DCs infected with both M. tuberculosis strains. Interleukin-10 secretion increased rapidly beginning from 4 hr after infection; in particular, H37Rv-infected DCs showed high secreted IL-10 levels, which peaked at 12 hr after infection. IL-12p70 was not detected at any time-point (Fig. 3a,b) . Interestingly, the phenotype of DCs infected with H37Rv showed a similar phenotype (Fig. 2 ) and cytokine profile (Fig. 3) to those of tolerogenic DCs. of one representative experiment of three independent experiments. n.s, not significant, *P < 0Á05, **P < 0Á01 and ***P < 0Á001, one-way analysis of variance. no OVA+NI-DCs: non-pulsed non-infected DCs, OVA+NI-DCs: OVA-pulsed non-infected DCs, OVA+Ra-DCs: OVA-pulsed H37Ra-infected DCs, OVA+Rv-DCs: OVA-pulsed H37Rv-infected DCs. The virulent M. tuberculosis strain-mediated conditioning of DCs into a tolerogenic phenotype is mediated by the IL-10 cascade Virulent H37Rv-infected DCs displayed a tolerogenic phenotype that impeded T-cell proliferation and polarization.
Among the factors induced by M. tuberculosis infection in DCs, IL-10 showed dramatically increased secretion from H37Rv-infected DCs compared with H37Ra-infected DCs beginning from early time-points after infection (Fig. 3) . Moreover, previous studies have reported that IL-10 The significance of the differences in expression between M. tuberculosis strains and between MOIs is indicated. All data are expressed as the mean AE SD (n = 3 samples) of one representative experiment of three independent experiments. +P < 0Á05, +++P < 0Á001 between M. tuberculosis-infected DCs and non-infected DCs; #P < 0Á05, ##P < 0Á01, ###P < 0Á001 between MOIs of the same strain; n.s., not significant; *P < 0Á05, **P < 0Á01 and ***P < 0Á001 between H37Ra-infected DCs (RaDCs) and H37Rv-infected DCs (Rv-DCs). NI-DCs: non-infected DCs. induces immune tolerance via DCs or tolerogenic DCs in vitro. 22, 23 Hence, we focused on IL-10 as a modulator of the tolerogenic DC phenotype. To verify the effect of IL-10 on the phenotype of M. tuberculosis-infected DCs, H37Rv and H37Ra were infected into DCs at an MOI of 1, followed by treatment of the cells with an anti-IL-10 mAb. At 24 hr after infection, the levels of cytokines (IL-10 and TNF-a) and DC surface markers (MHC-II, CD80, CD86, CD103, Tim-3, and PD-L1) were analysed (Fig. 4) . The anti-IL-10 neutralizing antibody functioned properly (Fig. 4a) . The M. tuberculosis infection-induced impairment in the expression of maturation markers, such as MHC-II, CD80 and CD86 in DCs was ameliorated by treatment with the anti-IL-10 neutralizing antibody (Fig. 4b) , whereas the expression of tolerogenic molecules, such as Tim-3, CD103 and PD-L1 were decreased by by the anti-IL-10 neutralizing antibody in DC treatment (Fig. 4c) .
To confirm these results, we generated DCs from bone marrow cells of IL-10 À/À mice and obtained similar results.
WT-DCs and DCs derived from IL-10 À/À mice (IL-10
À/À -DCs) were infected with H37Rv or H37Ra at an MOI of 1 for 24 hr. Afterwards, the expression of surface molecules such as CD80, CD86, MHC-II, CD103, Tim-3 and PD-L1 was analysed using flow cytometry, and the production of cytokines such as IL-10, IL-12p70 and TNF-a was analysed by ELISA (Fig. 5) . The M. tuberculosis infection-induced impairment in the expression of maturation markers such as MHC-II, CD80 and CD86 in WT-DCs was ameliorated in IL-10 À/À -DCs (Fig. 5a ), whereas the expression of tolerogenic molecules such as CD103, Tim-3 and PD-L1 was increased in M. tuberculosis-infected WT-DCs but decreased in IL-10 À/À -DCs (Fig. 5b) . Secretion level of TNF-a was higher in IL-10 two signalling pathways, the ERK1/2 mitogen-activated protein kinase (MAPK) and GSK-3b, in macrophages. 24, 25 To determine the role of different signalling pathways in M. tuberculosis-induced IL-10 secretion of BMDCs, we examined the activation of various MAPKs and GSK-3b, all of which are involved in the production from IL-10 in response to M. tuberculosis infection (Fig. 6) . We observed the most significant phosphorylation of p38 MAPK in H37Rv-infected DCs. In contrast, there were relatively lower levels of ERK1/2 MAPK phosphorylation compared to that of p38 MAPK, and no phosphorylation of JNK in DCs infected with either strain. We also observed that GSK-3b (Ser9) and its upstream, Akt, showed more significant phosphorylation following H37Rv infection than following H37Ra infection (Fig. 6a) . As the previous study reported that the phosphorylation of GSK-3b could be regulated by p38 MAPK, 26 we next examined the influence of p38 and ERK1/2 MAPK signalling on GSK-3b inhibitors in M. tuberculosis-infected DCs using specific inhibitors. However, the inhibition of p38 and ERK signalling had little influence on GSK-3b phosphorylation (Fig. 6b) . We next examined the involvement of the GSK-3b, p38, ERK and JNK MAPK signalling pathways in IL-10 production using inhibitors targeting members of each signalling pathway. Inhibition of p38 signalling exhibited the most significant decrease of IL-10 secretion, and ERK signalling inhibition had a partial effect; however, inhibiting GSK- The levels of DC surface stimulatory molecules (MHC class II, CD80, CD86) and tolerogenic molecules (CD103, Tim-3, PD-L1) were analysed via flow cytometry. All data are expressed as the mean AE SD (n = 3 samples) of one representative experiment of three independent experiments. n.s., not significant; *P < 0Á05, **P < 0Á01, and ***P < 0Á001, between IgG-treated DCs and anti-IL-10 mAb-treated DCs. NI: non-infected DCs, Ra: H37Ra-infected DCs, Rv: H37Rv-infected DCs.
ª 2017 John Wiley & Sons Ltd, Immunology, 151, 177-190 3b signalling had a minimal effect on IL-10 secretion from M. tuberculosis-infected DCs (Fig. 6c) . Taken together, our data suggest that IL-10, a cytokine that induces a tolerogenic DC phenotype in response to M. tuberculosis infection, is primarily regulated via the p38 MAPK signalling pathway and is partially regulated via the ERK and GSK-3b pathways. -DCs compared with that in H37Rv-infected WT-DCs (Fig. 7a,b) . Next, the expression of the master transcription factors of Th1 cells (T-bet) and Th2 cells (GATA-3) was evaluated via flow cytometry (Fig. 7c) . The expression of T-bet increased in T cells cocultured with H37Rv-infected IL-10 À/À -DCs, but there was no change in GATA-3 expression following H37Rv The secreted levels of tumour necrosis factor-a (TNF-a), IL-10, and IL-12p70 were determined by ELISA. All data are expressed as the mean AE SD (n = 3 samples) of one representative experiment of three independent experiments. n.s., not significant; *P < 0Á05, **P < 0Á01, and ***P < 0Á001, between M. tuberculosis- -DCs (Fig. 7d) . Moreover, PD-L1 was highly expressed in DCs infected with H37Rv (Fig. 2c) . Hence, we also co-cultured anti-PD-L1 blocking antibody-treated DCs with CD4 + T cells from OT-II mice. However, we found no difference in T-cell proliferation ability between co-culture with anti-PD-L1 blocking antibody-treated DCs and with non-treated DCs (see Supplementary material, Fig. S2 ). These results suggest that IL-10 is one factor that impedes effective T-cell responses by H37Rv-infected DCs.
Infection of IL-10
Discussion
Although numerous studies have examined the functions and alterations of macrophages during M. tuberculosis infection, few studies have reported the characteristics of DCs according to the virulence of M. tuberculosis. In this study, we investigated how virulent M. tuberculosis impairs and delays T-cell responses induced by interactions with DCs. A virulent M. tuberculosis strain drove DCs towards a tolerogenic phenotype by impairing DCactivating surface markers (CD80, CD86 and MHC class II) and by augmenting tolerogenic markers, such as PD-L1, CD103, Tim-3 and IDO, on DCs in an MOI-dependent manner, thereby suppressing Th1 responses. Of note, M. tuberculosis H37Rv-infected DCs showed markedly increased IL-10 production beginning from early timepoints of infection through activation of p38 MAPK signalling pathways. The generation of these tolerogenic DCs by the virulent M. tuberculosis strain was dependent on the production of IL-10 by DCs, as neither DCs generated from IL-10 À/À mice nor DCs treated with an anti-IL-10 neutralizing antibody generated tolerogenic DCs; consequently, the Th1-type T-cell response was restored in those DCs. The immunological environment in lung lesions at the early stage of infection can be regulated by virulent M. tuberculosis strains via the manipulation of innate immune cells and of the cytokine balance. Hence, impairment and delay of T-cell responses are generally believed to be a unique hallmark of early-stage infection with virulent M. tuberculosis. 20 To eliminate intracellular pathogens such as M. tuberculosis, it is essential to initiate an optimal T-cell response, especially an antigen-specific Th1 response characterized by IFN-c activity. Our previous study showed that the frequency of CD11b high DCs was significantly increased by infection with either M. tuberculosis H37Rv or H37Ra at early time-points, 15 although the frequency of this DC population in response to infection was not significantly different between the two strains at 14 days post-infection. However, an ex vivo experiment showed that infiltrated CD11b high DCs after virulent M. tuberculosis infection suppressed the Th1 response compared with naive CD11b high DCs. These previous results agree with our current results (Fig. 1) , indicating that virulent M. tuberculosis can suppress the protective Th1 response by driving DCs towards a tolerogenic phenotype.
Many studies reported that M. tuberculosis or its products impair DC maturation. For example, M. tuberculosis infection inhibit the maturation of human monocytederived DCs; M. tuberculosis-infected DCs exhibit an impaired ability to induce T cell proliferation; 21 M. tuberculosis antigen heat-shock protein 70 impairs the maturation of murine BMDCs; 27 and ManLAM, a glycolipid of M. tuberculosis, inhibits lipopolysaccharide-induced DC activation. 28 As another example, M. tuberculosis regulates granuloma formation, dissemination, bacterial growth and the host immune response by producing virulence factors such as ESX-1 secretion associated proteins. Carlsson et al. 29 demonstrated that the ESX-1 secretion system is required for granuloma persistence and survival in immune cells. Importantly, this system is present in virulent strains (M. tuberculosis H37Rv) but is largely absent from attenuated mycobacterial strains (H37Ra). and WT C57BL/6 mice, 32-34 even though IL-10 À/À mice showed enhanced IFN-c expression. 34 In contrast, a decreased bacterial load together with an enhanced IFN-c response in the lungs was detected in IL-10 À/À mice compared with WT mice. 11, 35 In another previous study, pretreatment of mice with an anti-IL-10 antibody resulted in an increase in the abundance of Ag85B-specific P25 T-cell receptor-transgenic CD4 + Th1 cells in the M. tuberculosisinfected lung on day 21 post-infection, whereas neutralization of TGF-b, another important suppressive cytokine in the lung, showed no effects on Th1 induction. 4 As revealed in this study, marked IL-10 production in DCs in response to virulent M. tuberculosis H37Rv infection is the most important factor that alters the phenotype of DCs towards a tolerogenic state and, consequently, suppresses the Th1 response (Figs 4, 5 and 7) . In addition, pulmonary DCs were reported to suppress the Th1 response via IL-10 production. 36 Hence, a virulent M. tuberculosis strain may exploit innately programmed suppressive mechanisms in the lungs to suppress the Th1 response at the early stage of infection.
Diverse signalling pathways have been known to regulate the production of IL-10. It was reported that ERK MAPK signalling is one major signalling pathway inducing IL-10 production in M. tuberculosis-infected macrophages. 37, 38 However, this study indicated that blocking the p38 pathway had a greater effect on IL-10 production than blocking the ERK signalling pathway (Fig. 6c) . This difference may have resulted from differences between cell types. According to previous studies, macrophages and DCs showed different degrees of ERK phosphorylation and IL-10 production in response to stimulation by Tolllike receptors 9 and 4. 39 In addition, IL-10 was produced by neutrophils 40 and human lung epithelial cells 41 through p38 MAPK signalling pathway activity in response to bacillus Calmette-Gu erin. These results indicated that the signalling pathways involved in IL-10 production may differ among innate immune cells in response to specific stimuli. The importance of IL-10 in DCs for the induction of immune tolerance has largely been demonstrated. For example, DCs genetically modified to express IL-10 exert suppressive effects in models of alloreactivity and autoimmunity. 42, 43 In this regard, Jarnicki et al. 44 demonstrated that inhibition of p38 MAPK-dependent IL-10 secretion from DCs led to stronger Th1 responses and weaker regulatory T-cell responses. These findings indicate that the tolerogenic DC phenotype generated in response to H37Rv can be overcome by inhibiting p38 signalling in DCs. Additionally, p38 may serve as an important therapeutic target, and p38 signalling is a potential mechanism for enhancing the efficacy of the Th1 response via vaccine or immunological interventions.
Current TB pathogenesis paradigms are changing in consideration of pathogen diversity because greater virulence has been identified in M. tuberculosis clinical isolates than was previously anticipated. 45 Hence, a further understanding of the characteristics of immune cells depending on M. tuberculosis virulence may facilitate the rational design of more effective therapeutic interventions, including immunotherapeutic vaccines. In conclusion, the findings of our study suggest that the virulent M. tuberculosis strain H37Rv impeded effective T-cell responses by inducing marked IL-10 release from infected DCs via the dominant activation of the p38 MAPK signalling pathway and partial regulation of the ERK MAPK signalling pathway. Hence, virulent M. tuberculosis may drive the production of pathogen-favourable tolerogenic DCs to diminish protective Th1 responses and may contribute to the inability of the host to eradicate the infection. Further functional analysis of the direct interplay between the components of M. tuberculosis that induce IL-10 production and alter DC maturation and the functionality of T cells may help us to understand how virulent M. tuberculosis evolved immunologically as the most highly adapted human pathogen.
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Additional Supporting Information may be found in the online version of this article: Figure S1 . The virulent Mycobacterium tuberculosis strain H37Rv displayed greater cytotoxicity to DCs than the attenuated M. tuberculosis strain H37Ra. Figure S2 . Blocking PD-L1 does not affect the tolerogenic function of H37Rv-infected dendritic cells. Figure S3 . Mycobacterium tuberculosis-infected dendritic cells (DCs) exert a suppressive effect on T-cell proliferation. CD4 + T cells were isolated from the spleen using a MACS system and labelled with 1Á25 lM CFSE.
